Morgan Gareth J, Prokaeva Tatiana
Boston University Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, United States.
Section of Hematology and Medical Oncology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, United States.
Front Immunol. 2025 Aug 1;16:1622207. doi: 10.3389/fimmu.2025.1622207. eCollection 2025.
Systemic AL amyloidosis is caused by deposition of monoclonal antibody light chains (LC) as insoluble amyloid fibrils in multiple tissues, leading to irreversible and eventually fatal organ damage. Each patient has a unique LC sequence that appears to define its propensity to aggregate. The complexity and diversity of LC sequences has impeded efforts to understand why some LCs aggregate to cause disease while others do not.
We investigated residue changes, relative to the inferred precursor germline sequences, in monoclonal LCs associated with AL amyloidosis and multiple myeloma (MM), derived from the AL-Base resource. Consensus matrices, calculated using healthy polyclonal repertoire sequences from Observed Antibody Space (OAS), were used to determine the relative frequency of each residue in the monoclonal LC sequences.
A subset of residues observed in AL-associated LCs was uncommon in the healthy repertoire, but these residues were highly diverse and were also observed in MM-associated LCs. We identified multiple positions that more frequently harbor uncommon residues in AL-associated LCs than OAS-derived LCs, including several positions that have previously been identified. However, each individual residue change occurs in only a small fraction of LCs, indicating that many types of residue change can contribute to disease. Furthermore, positions where residue changes occur most frequently were not enriched in amyloidosis-associated residues.
These data provide a framework for future investigations into sequence determinants of amyloid propensity, supporting efforts towards earlier recognition and diagnosis of AL amyloidosis.
系统性AL淀粉样变性是由单克隆抗体轻链(LC)以不溶性淀粉样纤维的形式沉积在多个组织中引起的,会导致不可逆转并最终致命的器官损伤。每个患者都有独特的LC序列,这似乎决定了其聚集倾向。LC序列的复杂性和多样性阻碍了人们对为何有些LC会聚集导致疾病而有些则不会的理解。
我们研究了与AL淀粉样变性和多发性骨髓瘤(MM)相关的单克隆LC中相对于推断的前体胚系序列的残基变化,这些数据来自AL-Base资源。使用从观察到的抗体空间(OAS)的健康多克隆库序列计算得出的一致性矩阵,来确定单克隆LC序列中每个残基的相对频率。
在与AL相关的LC中观察到的一部分残基在健康库中并不常见,但这些残基高度多样,在与MM相关的LC中也有观察到。我们确定了多个在与AL相关的LC中比源自OAS的LC更频繁地含有罕见残基的位置,包括几个先前已被确定的位置。然而,每个单独的残基变化仅发生在一小部分LC中,这表明许多类型的残基变化都可能导致疾病。此外,残基变化最频繁的位置并没有富集与淀粉样变性相关的残基。
这些数据为未来对淀粉样变性倾向的序列决定因素的研究提供了框架,支持了对AL淀粉样变性进行更早识别和诊断的努力。